首页> 美国政府科技报告 >Novel Therapeutic Targets to Inhibit Tumor Microenvironment Induced Castration-Resistant Prostate Cancer.

【24h】

Novel Therapeutic Targets to Inhibit Tumor Microenvironment Induced Castration-Resistant Prostate Cancer.

机译：新型治疗靶点抑制肿瘤微环境诱导去势抵抗前列腺癌。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yang, F.;
展开▼
作者单位

展开▼
年度 2017
页码 1-35
总页数 35
原文格式 PDF
正文语种 eng
中图分类
关键词
Prostate cancer; Therapeutics; Neoplasms; Cells(biology; Ligands; In vitro analysis; In vivo analysis; Androgens; Gene expression; Metastasis; Prostate cancer; Tumor microenvironment; Castration resistance; Ar; Tgf-; Mdv3100; Prostate stroma; Androgen-deprivation therapy;

机译：前列腺癌;治疗学;肿瘤;细胞（生物学;配体;体外分析;体内分析;雄激素;基因表达;转移;前列腺癌;肿瘤微环境;去势抵抗; ar; Tgf-; mdv3100;前列腺基质;雄激素剥夺治疗;

相似文献

外文文献
中文文献
专利

1. MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1???±) in the tumor microenvironments MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1???±) in the tumor microenvironments MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1???±) in the tumor microenvironments [J] . Xuejun Gong, Yebin Lu, Wei Wei, Biology Open . 2017,第2期

机译：MiR-142通过在肿瘤微环境中靶向缺氧诱导因子1（HIF-1 ???±）来调节人胰腺癌的增殖和侵袭MiR-142通过靶向低氧诱导因子1（HIF-在肿瘤微环境中的1 ???±）MiR-142通过在肿瘤微环境中靶向缺氧诱导因子1（HIF-1 ???±）来调节人胰腺癌的增殖和侵袭。
2. Novel targeted therapeutics for metastatic castration-resistant prostate cancer. [J] . Antonarakis ES, Carducci MA, Eisenberger MA Cancer letters . 2010,第1期

机译：用于转移性去势抵抗性前列腺癌的新型靶向疗法。
3. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. [J] . Dorai T, Cao YC, Dorai B, The Prostate . 2001,第4期

机译：姜黄素在人前列腺癌中的治疗潜力。三，姜黄素在体内抑制LNCaP前列腺癌细胞的增殖，诱导凋亡并抑制其血管生成。
4. Therapeutic Silencing of Hypoxia-Inducible Factor-1α Using Mixed Micelle Particles Inhibits Prostate Cancer Cell Growth under Hypoxia [C] . Xi-Qiu Liu, Meng-Hua Xiong, Jun Wang World biomaterials congress . 2012

机译：混合胶束粒子对缺氧诱导因子-1α的治疗沉默抑制缺氧条件下前列腺癌细胞的生长
5. Determination of novel metabolites of therapeutic agents used in the treatment of castration-resistant prostate cancer. [D] . Alyamani, Mohammad. 2017

机译：测定用于去势抵抗性前列腺癌的治疗剂的新代谢产物。
6. Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate Cancer [O] . Zhoulei Li, Peng He, Yali Long, 2021

机译：靶向肿瘤微环境条件的泮托拉唑和维生素C的药物修复可提高转移性阉割前列腺癌的抗癌作用
7. MK591, a second generation leukotriene biosynthesis inhibitor, prevents invasion and induces apoptosis in the bone-invading C4-2B human prostate cancer cells: implications for the treatment of castration-resistant, bone-metastatic prostate cancer. [O] . Sivalokanathan Sarveswaran, Ritisha Ghosh, Shravan Morisetty, 2015

机译：mK591是第二代白三烯生物合成抑制剂，可阻止侵入并诱导骨侵袭C4-2B人前列腺癌细胞的凋亡：对抗去势，骨转移性前列腺癌的治疗意义。
8. Novel Therapeutic Targets to Inhibit Tumor Microenvironment-Induced Castration-Resistant Prostate Cancer. [R] . Yang, F. 2014

机译：新型治疗靶点抑制肿瘤微环境诱导的去势抵抗前列腺癌。

Novel Therapeutic Targets to Inhibit Tumor Microenvironment Induced Castration-Resistant Prostate Cancer.

著录项

引文网络

相似文献

相关主题

期刊订阅